FDA Approves First Drug for Cholestatic Pruritus in Primary Biliary Cholangitis Dr. Kamal Kant Kohli22 March 2026 8:45 PM ISTThe U.S. Food and Drug Administration has approved linerixibat, marking the first treatment specifically indicated for cholestatic pruritus in...
GSK Gets USFDA Nod for Liver Disease-Related Itching Drug Lynavoy sheeba farhat20 March 2026 11:26 PM ISTLondon: The U.S. Food and Drug Administration approved GSK's drug for severe relentless itching caused by a type of liver disease, the company said...
FDA Expands Approval of GSK's RSV Vaccine to At-Risk Adults Aged 18-49 Dr. Kamal Kant Kohli15 March 2026 8:45 PM ISTThe U.S. Food and Drug Administration has expanded the approved use of Arexvy, an RSV vaccine developed by GSK, to include adults aged 18 to 49 who...
USFDA Expands Use of GSK's RSV Vaccine Arexvy to Adults 18-49 at Risk sheeba farhat14 March 2026 10:30 AM ISTBengaluru: British drugmaker GSK said on Friday the U.S. Food and Drug Administration has expanded the approved age range for its respiratory...
GSK Licenses Linerixibat to Alfasigma in Deal Worth Up to USD 690 Million sheeba farhat10 March 2026 11:03 PM ISTBengaluru: GSK said on Monday it will receive up to USD 690 million from Italian pharmaceutical company Alfasigma for the worldwide rights to...
GSK Pharma Names Ronojit Biswas as New CFO, Juby Chandy Moves to APAC Role Parthika Patel4 March 2026 8:39 PM ISTNew Delhi: GlaxoSmithKline (GSK) Pharmaceuticals Limited has approved the appointment of Ronojit Biswas as Whole-Time Director and Chief Financial...
Alembic Bags USFDA Approval for USD 27 Million Lamotrigine ODT Market Parthika Patel26 Feb 2026 10:14 PM ISTNew Delhi: Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug...
Sanofi Replaces CEO Paul Hudson Amid Vaccine Headwinds, Names Belen Garijo Successor sheeba farhat13 Feb 2026 2:00 PM ISTNew Delhi: French drugmaker Sanofi abruptly ousted its CEO Paul Hudson on Thursday, underscoring rising pressure from U.S. vaccine headwinds and a...
AI Reshapes Drug Development Workflows, But Breakthrough Molecules Still Elusive sheeba farhat27 Jan 2026 2:05 PM ISTDrug companies have announced a slew of deals for tools to unleash the promise of AI, seen as the biggest technological upheaval since the internet,...
GSK to Acquire RAPT Therapeutics for USD 2.2 Billion, Bolsters Food Allergy Drug Pipeline sheeba farhat26 Jan 2026 1:13 PM ISTLondon: Britain's GSK has agreed to buy RAPT Therapeutics for USD 2.2 billion, accessing the U.S. biotech's experimental drug to treat food allergies...
Malaria Vaccine Significantly Reduces Malaria Incidence in Children in real-world study Dr. Shravani Dali22 Jan 2026 9:00 PM ISTAn interim phase 4 analysis published in The Lancet Global Health reported that children who received the RTS,S/AS01E malaria vaccine experienced...
Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner sheeba farhat21 Jan 2026 5:47 PM ISTPfizer in December had warned that the next few years would be bumpy, beginning with 2026, due to lower sales of its COVID vaccine and treatment,...
